文献速递肝病消化道肿瘤与早癌

microRNA 193a-5p 通过调节核仁与纺锤体相关蛋白 1 的水平抑制肝癌发生

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.
PubMed 文献 · Gastroenterology · 2018-08-27

研究整合分析了 3 种小鼠肝癌模型及人肝癌组织的 miRNA 和 mRNA 表达谱,发现 MIR193A-5p 在肝癌中降低,其靶基因 NUSAP1 表达升高且与患者生存期缩短相关;MIR193A-5p 模拟物可抑制肝癌细胞增殖、存活、迁移、侵袭及裸鼠移植瘤生长。

要点

  • MIR193A-5p 在 3 种小鼠肝癌模型及人肝癌样本中较非肿瘤肝组织降低。
  • NUSAP1 为 MIR193A-5p 靶基因,低 MIR193A-5p 的肝癌细胞和组织中 NUSAP1 表达升高。
  • 肝癌样本中 NUSAP1 升高与患者生存期缩短相关。

核心结论

  • MIR193A-5p 似乎通过降低 NUSAP1 水平来阻止肝肿瘤发生。
  • 小鼠和人肝癌细胞及组织中 MIR193A-5p 水平降低,导致 NUSAP1 水平升高,与患者生存期缩短相关。
  • 对小鼠模型肿瘤中 miRNA 和 mRNA 的整合分析可帮助发现人类治疗靶点。

研究设计与样本

  • 研究分析 3 种小鼠肝癌模型(二乙基亚硝胺诱导、淋巴毒素α和淋巴毒素β条件表达、Myc 转基因可诱导表达)及雄性 C57BL/6 对照小鼠的 miRNA 和 mRNA 表达谱。
  • 在人肝癌细胞系(Huh7、Hep3B、JHH2)中表达 miRNA 模拟物或敲低 miRNA 和 mRNA,分析细胞活力、增殖、凋亡、迁移和侵袭,并在裸鼠中作为移植瘤分析。
  • 定量 146 份患者新鲜冷冻组织(125 例肝癌、17 份配对非肿瘤组织、4 份无癌症患者肝样本)的 miRNA 水平,用 Kaplan-Meier 曲线和 log-rank 检验分析其与患者生存时间的相关性。
  • 用 TaqMan 法在 237 例肝癌和 5 份非肿瘤肝样本中定量 NUSAP1 mRNA 水平。
  • 将计算机靶基因预测与 3 种小鼠模型的 mRNA 谱结合分析。

主要发现

  • 与未肿瘤肝组织相比,MIR193A-5p 水平在 3 种小鼠肿瘤模型及人肝癌样本的肝肿瘤中降低。
  • 在肝癌细胞中表达 MIR193A-5p 模拟物可降低增殖、存活、迁移、侵袭及裸鼠移植瘤生长。
  • NUSAP1 为 MIR193A-5p 的靶基因;MIR193A-5p 水平低的肝癌细胞和组织中 NUSAP1 表达升高。
  • 肝癌样本中 NUSAP1 水平升高与患者生存时间缩短相关。
  • 在 Huh7 细胞中敲低 NUSAP1 可降低增殖、存活、迁移及裸鼠移植瘤生长; hydrodynamic tail-vein 注射针对 NUSAP1 的小发夹 RNA 可减少 Akt1-Myc 诱导的小鼠肿瘤生长。

关键数值与推荐

  • 研究使用 146 份患者新鲜冷冻组织(125 例肝癌、17 份配对非肿瘤组织、4 份无癌症患者肝样本)定量 miRNA 水平并与生存时间做相关性分析。
  • 用 TaqMan 法在 237 例肝癌和 5 份非肿瘤肝样本中定量 NUSAP1 mRNA 水平。
  • miRNA 和 mRNA 表达谱数据已提交至 Gene Expression Omnibus(超级系列登录号 GSE102418)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We performed an integrated analysis to identify microRNAs (miRNAs) and messenger RNAs (mRNAs) with altered expression in liver tumors from 3 mouse models of hepatocellular carcinoma (HCC) and human tumor tissues. METHODS: We analyzed miRNA and mRNA expression profiles of liver tissues from mice with diethylnitrosamine-induced hepatocarcinogenesis, conditional expression of lymphotoxin alpha and lymphotoxin beta, or inducible expression of a Myc transgene (Tet-O-Myc mice), as well as male C57BL/6 mice (controls). miRNA mimics were expressed and miRNAs and mRNAs were knocked down in human (Huh7, Hep3B, JHH2) hepatoma cell lines; cells were analyzed for viability, proliferation, apoptosis, migration, and invasion. Cells were grown as xenograft tumors in nude mice and analyzed. We combined in silico target gene prediction with mRNA profiles from all 3 mouse models. We quantified miRNA levels in 146 fresh-frozen tissues from patients (125 HCCs, 17 matched nontumor tissues, and 4 liver samples from patients without cancer) and published human data sets and tested correlations with patient survival times using Kaplan-Meier curves and the log-rank test. Levels of NUSAP1 mRNA were quantified in 237 HCCs and 5 nontumor liver samples using the TaqMan assay. RESULTS: Levels of the miRNA 193a-5p (MIR193A-5p) were reduced in liver tumors from all 3 mouse tumor models and in human HCC samples, compared with nontumor liver tissues. Expression of a MIR193A-5p mimic in hepatoma cells reduced proliferation, survival, migration, and invasion and their growth as xenograft tumors in nude mice. We found nucleolar and spindle-associated protein 1 (NUSAP1) to be a target of MIR193A-5p; HCC cells and tissues with low levels of MIR193A-5p had increased expression of NUSAP1. Increased levels of NUSAP1 in HCC samples correlated with shorter survival times of patients. Knockdown of NUSAP1 in Huh7 cells reduced proliferation, survival, migration, and growth as xenograft tumors in nude mice. Hydrodynamic tail-vein injections of a small hairpin RNA against NUSAP1 reduced growth of Akt1-Myc-induced tumors in mice. CONCLUSIONS: MIR193A-5p appears to prevent liver tumorigenesis by reducing levels of NUSAP1. Levels of MIR193A-5p are reduced in mouse and human HCC cells and tissues, leading to increased levels of NUSAP1, associated with shorter survival times of patients. Integrated analyses of miRNAs and mRNAs in tumors from mouse models can lead to identification of therapeutic targets in humans. The currently reported miRNA and mRNA profiling data have been submitted to the Gene Expression Omnibus (super-series accession number GSE102418).

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Roy S, Hooiveld GJ, Seehawer M, et al. microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis. Gastroenterology. 2018. PMID: 30165047. doi:10.1053/j.gastro.2018.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。